Table 2.

Clinical Characteristics and Post–Cancer TB Diagnosis Status of Cancer Patients

		Cancer patients with no TB		Post–Cancer TB diagnosis
Characteristics	Cancer Patients (n)	n	%	n	%	p–value
Cancer type						< 0.001
Liver and Bile Duct CA	12,948	12,888	99.54	60	0.46
Female organ CA	3,701	3,671	99.19	30	0.81
Breast CA	3,647	3,619	99.23	28	0.77
Colorectal CA	3,224	3,190	98.95	34	1.0.5
Lung CA (no histology)	2,656	2,599	97.85	57	2.15
Head and neck CA	2,376	2,340	98.48	36	1.52
Hematopoietic	1,844	1,790	97.07	54	2.93
Unknown primary CA	1,591	1,566	98.43	25	1.57
Skin CA	1,308	1,285	98.24	23	1.76
Lung CA (histology)	1,253	1,231	98.24	22	1.76
Digestive organ CA	1,207	1,194	98.92	13	1.08
Lymphoma	1,114	1,080	96.95	34	3.05
Thyroid CA	963	954	99.07	9	0.93
Urinary tract CA	902	885	98.12	17	1.88
Male organ CA	852	836	98.12	16	1.88
Other CA	831	822	98.92	9	1.08
Brain CA	531	526	99.06	5	0.94
Total	40,948	40,476	98.85	472	1.15
Cancer stage (by extent)
Localized	2,483	2,442	98.35	41	1.65
Regional	5,834	5,767	98.85	67	1.15
Distant	8,066	7,991	99.07	75	0.93
Not applicable	2,381	2,309	96.98	72	3.02
Unknown stage	22,184	21,967	99.02	217	0.98
Total	40,948	40,476	98.85	472	1.15
Cancer treatment						0.018
No treatment	22,361	22,121	98.93	240	1.07
Only SURG	6,685	6,600	98.73	85	1.27
Only CMT	2,942	2,888	98.16	54	1.84
Only RT	1,841	1,822	98.97	19	1.03
SURG+CMT	4,148	4,110	99.08	38	0.92
SURG+RT	1,304	1,290	98.93	14	1.07
CMT + RT	824	813	98.67	11	1.33
SURG+CMT+RT	843	832	98.7	11	1.3
Total	40,948	40,476	98.85	472	1.15